Company
Headquarters: Oslo, Norway
kr1.23 Billion
NOK as of July 1, 2024
US$115.0 Million
| Company | Market Cap (USD) |
|---|---|
| GE HealthCare | $37.81 B |
| Veeva Systems Inc. | $36.08 B |
| M3, Inc. | $11.14 B |
| Change Healthcare Inc. | $9.03 B |
| Pro Medicus Limited | $8.96 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Carasent ASA, an investment management company, provides cloud-based medical record services to the private and public health care industry in the Nordic region. The company develops Webdoc, a cloud based EMR-system; and digital platform for interactive health care that enables healthcare providers to communicate with their patients through digital services, such as video, chat, and other channels. It also provides Ad Voca, a Web application; Ad Opus; and smart integration solutions. The company was formerly known as Apptix ASA and changed its name to Carasent ASA in May 2019. Carasent ASA was founded in 1997 and is based in Oslo, Norway.
Carasent ASA has the following listings and related stock indices.
Stock: OSE: CARA
Stock: OSE: CARAO
Stock: FSX: C34